<DOC>
	<DOCNO>NCT01154621</DOCNO>
	<brief_summary>The aim study examine safety tolerability single dose AZD9742 elderly individual .</brief_summary>
	<brief_title>Assessing Safety Tolerability Single IV Dose AZD9742 Healthy Elderly Male Female Subjects</brief_title>
	<detailed_description />
	<criteria>Male female volunteer age 65 year older suitable vein cannulation repeat venipuncture , good health ( base medical history physical examination clinical laboratory test ) judge investigator . Female volunteer must postmenopausal ( cessation regular menses 12 month follicle stimulate hormone level 40IU/L abd estradiol less 20ng/mL . Male volunteer willing use barrier contraception , ie , condom , day dose 3 month dose investigational product . History clinically significant disease disorder , opinion Investigator , may either put volunteer risk participation study , influence result volunteer 's ability participate History presence GI , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug judge Investigator . Any clinically significant illness , medical/surgical procedure , trauma within 4 week first administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Double-blind</keyword>
	<keyword>Randomized</keyword>
	<keyword>Placebo-controlled study</keyword>
	<keyword>Safety tolerability single intravenous dose AZD9742 healthy elderly volunteer</keyword>
</DOC>